A detailed history of Klp Kapitalforvaltning As transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 12,900 shares of CRL stock, worth $2.16 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,900
Previous 10,100 27.72%
Holding current value
$2.16 Million
Previous $1.53 Million 31.72%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$145.57 - $178.99 $407,596 - $501,172
2,800 Added 27.72%
12,900 $2.02 Million
Q2 2025

Jul 23, 2025

BUY
$99.75 - $151.89 $19,950 - $30,377
200 Added 2.02%
10,100 $1.53 Million
Q1 2025

May 06, 2025

SELL
$150.52 - $190.14 $1.44 Million - $1.83 Million
-9,600 Reduced 49.23%
9,900 $1.49 Million
Q4 2024

Feb 11, 2025

BUY
$178.58 - $220.69 $3.48 Million - $4.3 Million
19,500 New
19,500 $3.6 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.